Histone methyltransferase G9a and H3K9 dimethylation inhibit the self-renewal of glioma cancer stem cells

Molecular and Cellular Biochemistry

Volumn 394, Issue 1, 2014, Pages 23-30

  Tao, Hong ^a   Li, Haiying ^b   Su, Yanhuang ^a   Feng, Danni ^a   Wang, Xilong ^a   Zhang, Chun ^c   Ma, Hui ^a   Hu, Qikuan ^a,c  

^a NINGXIA MEDICAL UNIVERSITY   (China)

^b Inner Mongolia Wulanchabu Medical College   (China)

^c Ningxia Key Lab of Cerebrocranial Diseases   (China)

Author keywords

Cancer stem cells; G9a; H3K9me2; Self renewal

Indexed keywords

CD133 ANTIGEN; HISTONE METHYLTRANSFERASE; HISTONE METHYLTRANSFERASE G9A; HISTONE METHYLTRANSFERASE H3K9; N (1 BENZYL 4 PIPERIDINYL) 2 (HEXAHYDRO 4 METHYL 1H 1,4 DIAZEPIN 1 YL) 6,7 DIMETHOXY 4 QUINAZOLINAMINE; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; AZEPINE DERIVATIVE; EHMT2 PROTEIN, HUMAN; ENZYME INHIBITOR; GLYCOPROTEIN; HISTOCOMPATIBILITY ANTIGEN; HISTONE; HISTONE LYSINE METHYLTRANSFERASE; LEUKOCYTE ANTIGEN; LYSINE; PEPTIDE; QUINAZOLINE DERIVATIVE; SOX2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX;

ARTICLE; ASTROCYTOMA; CELL CULTURE; CELL DIFFERENTIATION; CELL RENEWAL; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENHANCER REGION; FLOW CYTOMETRY; GENE EXPRESSION; GENE REPRESSION; GENETIC TRANSFECTION; GLIOMA CELL LINE; GLIOMA STEM CELL; HISTONE DEMETHYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; NEURAL STEM CELL; PLURIPOTENT STEM CELL; PROMOTER REGION; UPREGULATION; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; BRAIN TUMOR; CANCER STEM CELL; CELL PROLIFERATION; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; GLIOMA; METABOLISM; METHYLATION; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANTIGENS, CD; AZEPINES; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; GLYCOPROTEINS; HISTOCOMPATIBILITY ANTIGENS; HISTONE-LYSINE N-METHYLTRANSFERASE; HISTONES; HUMANS; LYSINE; METHYLATION; NEOPLASTIC STEM CELLS; PEPTIDES; PROMOTER REGIONS, GENETIC; QUINAZOLINES; SIGNAL TRANSDUCTION; SOXB1 TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 84911915082     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-014-2077-4     Document Type: Article

References (18)

1. Watanabe A, Yamada Y, Yamanaka S (2013) Epigenetic regu- lation in pluripotent stem cells: a key to breaking the epigenetic barrier. Philos Trans R Soc Lond B 368(1609):20120292
2. Barrero MJ, Izpisua Belmonte JC (2013) Polycomb complex recruitment in pluripotent stem cells. Nat Cell Biol 15(4):348–350
3. Shinkai Y, Tachibana M (2011) H3K9 methyl-transferase G9a and the related molecule GLP. Genes Dev 25(8):781–788
4. Epsztejn-Litman S, Feldman N, Abu-Remaileh M, Shufaro Y, Gerson A et al (2008) De novo DNA methylation promoted by G9a prevents reprogramming of embryonically silenced genes. Nat Struct Mol Biol 15(11):1176–1183
5. Wen B, Wu H, Shinkai Y, Irizarry RA, Feinberg AP (2009) Large histone H3 lysine 9 dimethylated chromatin blocks distinguish differentiated from embryonic stem cells. Nat Genet 41(2): 246–250
6. McDonald OG, Wu H, Timp W, Doi A, Feinberg AP (2011) Genome-scale epigenetic reprogramming during epithelial-to- mesenchymal transition. Nat Struct Mol Biol 18(8):867–874
7. Chen SF, Chang YC, Nieh S, Liu CL, Yang CY et al (2012) Nonadhesive culture system as a model of rapid sphere formation with cancer stem cell properties. PLoS One 7(2):e31864
8. Pellacani D, Packer RJ, Frame FM, Oldridge EE, Berry PA et al (2011) Regulation of the stem cell marker CD133 is independent of promoter hypermethylation in human epithelial differentiation and cancer. Mol Cancer 10:94
9. Li Z, Liu C, Xie Z, Song P, Zhao RC et al (2011) Epigenetic dysregulation in mesenchymal stem cell aging and spontaneous differentiation. PLoS One 6(6):e20526
10. Leis O, Eguiara A, Lopez-Arribillaga E, Alberdi MJ, Hernandez- Garcia S et al (2012) Sox2 expression in breast tumours and activation in breast cancer stem cells. Oncogene 31(11): 1354–1365
11. Shi Y, Desponts C, Do JT, Hahm HS, Schöler HR, Ding S (2008) Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 3(5):568–574
12. Chen X, Skutt-Kakaria K, Davison J, Ou YL, Choi E et al (2012) G9a/GLP-dependent histone H3K9me2 patterning during human hematopoietic stem cell lineage commitment. Genes Dev 26(22): 2499–2511
13. Tabu K, Kimura T, Sasai K, Wang L, Bizen N et al (2010) Analysis of an alternative human CD133 promoter reveals the implication of Ras/ERK pathway in tumor stem-like hallmarks. Mol Cancer 9:39
14. Tabu K, Sasai K, Kimura T, Wang L, Aoyanagi E et al (2008) Promoter hypomethylation regulates CD133 expression in human gliomas. Cell Res 18(10):1037–1046
15. Hu Q, Zhang L, Wen J, Wang S, Li M et al (2010) The Egf receptor-Sox2-Egf receptor feedback loop positively regulates the selfrenewal of neural precursor cells. Stem Cells 28(2):279–286
16. Gangemi RM, Griffero F, Marubbi D, Perera M, Capra MC et al (2009) SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity. Stem Cells 27(1):40–48
17. Sharma S, Kelly TK, Jones PA (2010) Epigenetics in cancer. Carcinogenesis 31(1):27–36
18. Ruau D, Ensenat-Waser R, Dinger TC, Vallabhapurapu DS, Rolletschek A et al (2008) Pluripotency associated genes are reactivated by chromatin-modifying agents in neurosphere cells. Stem Cells 26(4):920–926